發(fā)布時(shí)間：2018-09-01 13:57

【摘要】：背景與目的缺血性心臟病是我國目前致死率和致殘率最高的疾病之一。雖然及時(shí)恢復(fù)缺血心肌血流灌注是治療的重要手段,但心肌缺血后最終心肌梗死面積大約一半以上是由缺血再灌注損傷(ischemia reperfusion injury,IRI)所致。心肌缺血再灌注過程中局部微環(huán)境產(chǎn)生的緩激肽、腺苷、氫離子等可興奮心肌缺血敏感性傳入神經(jīng)元,并將傷害感受信號(hào)經(jīng)背根神經(jīng)節(jié)(dorsal root ganglia,DRG)和相應(yīng)節(jié)段脊髓上傳至高級(jí)中樞。脊髓背角淺層尤其是脊髓背角II層又稱膠狀質(zhì)SG(substantia gelatinosa,SG),是傷害性信息向中樞傳遞的初級(jí)門戶,主要由興奮性中間神經(jīng)元組成,對(duì)傷害性刺激信息的傳入與整合具有重要的調(diào)控作用。心肌缺血引起相應(yīng)節(jié)段脊髓神經(jīng)元興奮,進(jìn)而通過交感反射釋放神經(jīng)遞質(zhì)加重心肌細(xì)胞損傷。因此,調(diào)控脊髓背角神經(jīng)元興奮性,抑制神經(jīng)遞質(zhì)的釋放,可能會(huì)減輕缺血性心肌損傷。本課題組前期的研究發(fā)現(xiàn),鞘內(nèi)嗎啡預(yù)處理(intrathecal morphine preconditioning,ITMP)可明顯減輕心肌缺血后損傷。然而,ITMP對(duì)遠(yuǎn)端心臟發(fā)揮保護(hù)作用的神經(jīng)機(jī)制尚未闡明,本研究擬探討ITMP對(duì)抗心肌IRI的神經(jīng)信號(hào)調(diào)控機(jī)制。方法SD雄性大鼠,體重180~280 g,成功建立鞘內(nèi)置管模型。本實(shí)驗(yàn)分兩個(gè)系列進(jìn)行研究。第一部分:探討ITMP對(duì)大鼠心肌缺血后脊髓SG神經(jīng)元興奮性的神經(jīng)調(diào)控機(jī)制。實(shí)驗(yàn)隨機(jī)分為6組(n=6),假手術(shù)組(SHAM組)、缺血再灌注組(IR組)、鞘內(nèi)嗎啡預(yù)處理組(ITMP組)、δ受體阻斷劑NTD+ITMP組(NTD+ITMP組)、κ受體阻斷劑nor-BNI+ITMP組(nor-BNI+ITMP組)和μ受體阻斷劑CTOP+ITMP組(CTOP+ITMP組)。所有組除SHAM組外均以結(jié)扎冠狀動(dòng)脈左前降支缺血30 min、再灌注120 min的方法建立心肌缺血再灌注損傷模型。ITMP組在心肌缺血前30 min經(jīng)鞘內(nèi)泵注嗎啡(3μg·kg-1,10μl)5 min,停止5 min,共3個(gè)循環(huán);I/R組給予等容量生理鹽水。NTD+ITMP組、nor-BNI+ITMP組以及CTOP+ITMP組分別于嗎啡預(yù)處理前10 min鞘內(nèi)分別注射NTD(1 ug·ul-1,10 ul)、nor-BNI(1 ug·ul-1,10 ul)、CTOP(1 ug·ul-1,10 ul)。于再灌注10 min結(jié)束時(shí),急性分離大鼠T2~T6脊髓,制備脊髓組織切片,采用全細(xì)胞膜片鉗技術(shù)對(duì)大鼠SG神經(jīng)元進(jìn)行動(dòng)作電位(action potential,AP)記錄,包括SG神經(jīng)元靜息電位(resting potential,RP)、動(dòng)作電位閾值(threshold of action potential,APT)、動(dòng)作電位峰值(peak of action potential,APP)、動(dòng)作電位時(shí)程[用半峰時(shí)間(APD50)表示],記錄步階電流40、60、80、100 p A誘發(fā)的動(dòng)作電位個(gè)數(shù)。第二部分:研究ITMP對(duì)心肌缺血后損傷及相關(guān)神經(jīng)遞質(zhì)釋放的影響。實(shí)驗(yàn)分組以及動(dòng)物模型建立同第一部分研究。實(shí)驗(yàn)過程中記錄心律失常的發(fā)生率。于再灌注120 min時(shí)處死大鼠,取心肌組織,測定梗死區(qū)(IS)體積與缺血危險(xiǎn)區(qū)(ARR)面積,計(jì)算IS/ARR比值;Western blot法檢測T2~T6脊髓和DRG組織中c-fos蛋白表達(dá);免疫熒光觀察T2~T6脊髓背角P物質(zhì)(substance P,SP)、降鈣素基因相關(guān)肽(calcitonin gene related peptide,CGRP)和內(nèi)嗎啡肽2(endomorphin 2,EM-2)的釋放水平以及DRG中的SP和CGRP的表達(dá)情況。結(jié)果第一部分:探討ITMP對(duì)大鼠心肌缺血后脊髓背角SG神經(jīng)元興奮性的神經(jīng)調(diào)控機(jī)制結(jié)果發(fā)現(xiàn),心肌缺血后大鼠脊髓背角SG神經(jīng)元興奮性增強(qiáng),表現(xiàn)為APT降低,APP增加,相同步階電流刺激電流下誘發(fā)的AP個(gè)數(shù)增多;而ITMP顯著逆轉(zhuǎn)IR組大鼠SG神經(jīng)元的興奮性升高,表現(xiàn)為APT升高,APP降低,相同步階電流刺激下誘發(fā)的AP個(gè)數(shù)減少。各組大鼠脊髓背角SG神經(jīng)元RP和APD50差異無統(tǒng)計(jì)學(xué)意義。與ITMP組相比,通過預(yù)先分別給予δ、κ、μ三種阿片受體阻斷劑可以取消SG神經(jīng)元興奮性的降低,表現(xiàn)為APT降低,APP增高,相同步階刺激下誘發(fā)的AP個(gè)數(shù)增加。第二部分:研究ITMP對(duì)心肌缺血后損傷及相關(guān)神經(jīng)遞質(zhì)釋放的影響1.ITMP介導(dǎo)的大鼠心肌保護(hù)效應(yīng):ITMP可明顯降低心肌梗死體積和心律失常發(fā)生率,且NTD、nor-BNI和CTOP完全阻斷ITMP的心肌保護(hù)作用。2.ITMP對(duì)大鼠心肌缺血后脊髓SP、CGRP和EM-2表達(dá)水平的影響:免疫熒光結(jié)果顯示,SP、CGRP和EM-2免疫陽性產(chǎn)物在脊髓背角淺層存在共表達(dá)。心肌缺血后脊髓背角SP和CGRP大量表達(dá),ITMP可以顯著抑制心肌缺血后脊髓背角SP和CGRP的表達(dá)上調(diào);EM-2在心肌缺血后脊髓背角的表達(dá)無明顯變化,而ITMP可以顯著上調(diào)心肌缺血后EM-2的表達(dá)。3.ITMP對(duì)大鼠心肌缺血后DRG內(nèi)SP和CGRP表達(dá)水平的影響:免疫熒光結(jié)果顯示心肌缺血后,DRG內(nèi)SP和CGRP表達(dá)均顯著增加,ITMP可顯著減少心肌缺血再灌注損傷誘導(dǎo)的DRG內(nèi)SP和CGRP的表達(dá)增加。4.ITMP對(duì)大鼠心肌缺血后脊髓背角和DRG內(nèi)c-fos表達(dá)的影響:Western blot結(jié)果證明,心肌缺血后大鼠脊髓背角和DRG內(nèi)c-fos明顯增多,ITMP可顯著抑制心肌缺血后大鼠脊髓背角和DRG內(nèi)c-fos表達(dá)的增多;三種中樞阿片受體阻斷劑能取消ITMP的抑制效應(yīng)。結(jié)論ITMP對(duì)在體大鼠心肌缺血后損傷具有保護(hù)作用。其可能的神經(jīng)調(diào)控機(jī)制:1.ITMP心肌保護(hù)作用與降低心肌缺血后大鼠脊髓SG神經(jīng)元的興奮性,減輕心臟傷害感受反應(yīng),調(diào)控脊髓水平傷害感受信號(hào)有關(guān),δ、κ、μ三種中樞阿片受體均參與了這種保護(hù)作用。2.ITMP心肌保護(hù)作用與抑制心肌缺血后脊髓SP和CGRP等神經(jīng)遞質(zhì)的過度釋放,促進(jìn)EM-2在脊髓水平的釋放,降低神經(jīng)元興奮性有關(guān)。
[Abstract]:BACKGROUND & OBJECTIVE Ischemic heart disease is one of the most lethal and disabled diseases in China at present. Although timely recovery of ischemic myocardial perfusion is an important means of treatment, more than half of the final myocardial infarction area after myocardial ischemia is caused by ischemia reperfusion injury (IRI). Bradykinin, adenosine and hydrogen ions produced in the local microenvironment during reperfusion excite myocardial ischemia-sensitive afferent neurons and upload nociceptive signals via dorsal root ganglia (DRG) and corresponding segments of the spinal cord to the higher central nervous system. Gelatinosa, SG, is the primary portal of nociceptive information to the central nervous system. It is mainly composed of excitatory intermediate neurons. It plays an important role in regulating the input and integration of nociceptive stimulus information. Myocardial ischemia induces excitation of spinal neurons in corresponding segments, and then releases neurotransmitters through sympathetic reflex to aggravate myocardial injury. Previous studies have shown that intrathecal morphine preconditioning (ITMP) can significantly reduce myocardial ischemic injury. However, ITMP plays a protective role in the distal heart. Methods SD male rats, weighing 180-280 g, were successfully established intrathecal catheterization model. This study was divided into two series. Part I: To investigate the neural regulation mechanism of ITMP on the excitability of spinal SG neurons after myocardial ischemia in rats. Six groups (n=6), sham operation group (SHAM group), ischemia-reperfusion group (IR group), intrathecal morphine preconditioning group (ITMP group), delta receptor blocker NTD+ITMP group (NTD+ITMP group), kappa receptor blocker nor-BNI+ITMP group (nor-BNI+ITMP group) and mu receptor blocker CTOP+ITMP group (CTOP+ITMP group). All groups except SHAM group were ligated with 30 mi left anterior descending coronary artery ischemia. The model of myocardial ischemia-reperfusion injury was established by reperfusion for 120 minutes.Morphine was injected intrathecally 30 minutes before myocardial ischemia in ITMP group for 5 minutes and stopped for 5 minutes.The same volume of saline was given to I/R group.NTD+ITMP group,nor-BNI+ITMP group and CTOP+ITMP group were injected intrathecally 10 minutes before morphine preconditioning respectively. NTD (1 ug.ul-1,10 ul), nor-BNI (1 ug.ul-1,10 ul), CTOP (1 ug.ul-1,10 ul). At the end of 10 minutes of reperfusion, the T2-T6 spinal cord of rats was separated and the spinal cord tissue sections were prepared. The action potential (AP) of SG neurons, including resting potential (R-P) of SG neurons, were recorded by whole-cell patch clamp technique. P, threshold of action potential (APT), peak of action potential (APP), action potential duration (expressed as APD50), and the number of action potentials evoked by step current 40, 60, 80, 100 P A were recorded. Part II: To study the effects of ITMP on myocardial ischemia injury and related neurotransmitter release. The incidence of arrhythmia was recorded during the experiment. Rats were sacrificed at 120 minutes after reperfusion. The infarct area (IS) and the area of ischemic risk area (ARR) were measured and the ratio of IS to ARR was calculated. The expression of c-fos protein in spinal cord and DRG tissues of T2-T6 was detected by Western blot. The release levels of substance P (SP), calcitonin gene related peptide (CGRP) and endomorphin 2 (EM-2) and the expression of SP and CGRP in DRG were observed by immunofluorescence. Results Part I: To investigate the excitability of ITMP on SG neurons in spinal dorsal horn after myocardial ischemia in rats. The results showed that the excitability of SG neurons in spinal dorsal horn was enhanced after myocardial ischemia, which was manifested by the decrease of APT, the increase of APP and the increase of the number of AP induced by synchronous current stimulation, while ITMP significantly reversed the increase of excitability of SG neurons in IR group, which was manifested by the increase of APT, the decrease of APP and the induction of synchronous current stimulation. There was no significant difference in RP and APD50 of SG neurons in the spinal dorsal horn of each group. Compared with ITMP group, the decreased excitability of SG neurons could be cancelled by pretreatment with delta, kappa, and mu opioid receptor blockers respectively. The decrease of APT, the increase of APP and the increase of AP induced by synchronous stimuli were observed. Effects of ITMP on myocardial ischemia injury and related neurotransmitter release 1. ITMP-mediated myocardial protective effect: ITMP can significantly reduce myocardial infarction volume and arrhythmia incidence, and NTD, nor-BNI and CTOP completely block the myocardial protective effect of ITMP. 2. ITMP on the expression of SP, CGRP and EM-2 in spinal cord after myocardial ischemia in rats Immunofluorescence showed that SP, CGRP and EM-2 immunoreactive products co-expressed in the superficial layer of the spinal dorsal horn. After myocardial ischemia, SP and CGRP were overexpressed in the spinal dorsal horn. ITMP could significantly inhibit the up-regulation of SP and CGRP expression in the spinal dorsal horn after myocardial ischemia. EM-2 expression in the spinal dorsal horn after myocardial ischemia did not change significantly, but ITMP could significantly up-regulate the Regulation of EM-2 expression after myocardial ischemia. 3. Effect of ITMP on SP and CGRP expression in DRG after myocardial ischemia in rats: Immunofluorescence results showed that SP and CGRP expression in DRG increased significantly after myocardial ischemia. ITMP could significantly reduce the expression of SP and CGRP in DRG induced by myocardial ischemia-reperfusion injury. Effects of three central opioid receptor blockers on the expression of c-fos in dorsal horn and DRG: Western blot showed that the expression of c-fos in spinal dorsal horn and DRG increased significantly after myocardial ischemia in rats. ITMP significantly inhibited the expression of c-fos in spinal dorsal horn and DRG after myocardial ischemia in rats. Postoperative neuroprotective effects of ITMP on myocardial ischemia are related to decreasing excitability of spinal SG neurons, reducing cardiac nociceptive response, and regulating nociceptive signals at spinal cord level. Three central opioid receptors, delta, kappa and mu, are involved in this protective effect. 2. The protective effect is related to inhibiting the excessive release of neurotransmitters such as SP and CGRP in the spinal cord after myocardial ischemia, promoting the release of EM-2 at the spinal cord level and reducing the excitability of neurons.
【學(xué)位授予單位】：安徽醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R614

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 曲鋒 ,邱學(xué)才;皮質(zhì)類固醇激素對(duì)神經(jīng)元興奮性有調(diào)控作用[J];生理科學(xué)進(jìn)展;1992年04期

2 涂明義,李朝武,張?zhí)K明,聶海嶺,馬燕妮,成勇,毛高峰,方煌,張瑾;納洛酮對(duì)大鼠額葉皮層神經(jīng)元興奮性的影響[J];中華神經(jīng)科雜志;2004年06期

3 劉之紅;劉之英;;35例癲癇患者的康復(fù)指導(dǎo)[J];中國實(shí)用醫(yī)藥;2012年07期

4 尚偉,謝安木,曹麗麗,趙秀鶴;熱休克蛋白與神經(jīng)元興奮性損傷[J];國外醫(yī)學(xué)(生理、病理科學(xué)與臨床分冊(cè));1997年04期

5 鄭琴;;大鼠骨癌痛模型中小直徑背根神經(jīng)節(jié)神經(jīng)元興奮性增強(qiáng)[J];中國疼痛醫(yī)學(xué)雜志;2012年09期

6 尤春景;用F波評(píng)價(jià)節(jié)段運(yùn)動(dòng)神經(jīng)元興奮性[J];國外醫(yī)學(xué)(物理醫(yī)學(xué)與康復(fù)學(xué)分冊(cè));1993年01期

7 唐紅梅;董軍;陸大祥;戚仁斌;;MCP-1通過影響鉀通道的開放進(jìn)而影響神經(jīng)元興奮性突觸后電流[J];中國病理生理雜志;2010年10期

8 董惠;王小新;吳力娟;段偉松;許蕾;;突變TDP43誘導(dǎo)神經(jīng)元興奮性升高以及雙甲氧姜黃素的神經(jīng)保護(hù)作用[J];腦與神經(jīng)疾病雜志;2013年06期

9 王得文;李愛林;;亞低溫治療對(duì)神經(jīng)元興奮性毒性損傷影響的研究[J];海南醫(yī)學(xué);2012年22期

10 郁毅剛,徐如祥,姜曉丹,柯以銓;腦損傷保護(hù)作用的基礎(chǔ)研究:神經(jīng)元興奮性氨基酸損傷保護(hù)模型的建立[J];中國臨床康復(fù);2004年28期

相關(guān)會(huì)議論文 前5條

1 謝勇;;通過分岔控制改變神經(jīng)元的興奮性類型[A];第十二屆全國非線性振動(dòng)暨第九屆全國非線性動(dòng)力學(xué)和運(yùn)動(dòng)穩(wěn)定性學(xué)術(shù)會(huì)議論文集[C];2009年

2 劉丙方;王唯晰;楊慧;徐群淵;;Agrin的腦發(fā)育學(xué)研究及培養(yǎng)海馬神經(jīng)元興奮性改變對(duì)其表達(dá)的影響[A];解剖學(xué)雜志——中國解剖學(xué)會(huì)2002年年會(huì)文摘匯編[C];2002年

3 王艷芹;曹榮;陳良為;;神經(jīng)激肽對(duì)基底核神經(jīng)元興奮性毒性損傷的干預(yù)作用[A];Proceedings of the 7th Biennial Meeting and the 5th Congress of the Chinese Society for Neuroscience[C];2007年

4 任維;;藥物和刺激誘導(dǎo)的神經(jīng)元興奮性的長時(shí)程可塑性[A];中國神經(jīng)科學(xué)學(xué)會(huì)第九屆全國學(xué)術(shù)會(huì)議暨第五次會(huì)員代表大會(huì)論文摘要集[C];2011年

5 唐紅梅;董軍;陸大祥;戚仁斌;;MCP-1通過影響鉀通道的開放進(jìn)而影響神經(jīng)元興奮性突觸后電流[A];中國病理生理學(xué)會(huì)第九屆全國代表大會(huì)及學(xué)術(shù)會(huì)議論文摘要[C];2010年

相關(guān)重要報(bào)紙文章 前2條

1 通訊員 周煒 記者 陳寧;浙大醫(yī)學(xué)部一項(xiàng)研究找到癲癇發(fā)病新機(jī)制[N];浙江日?qǐng)?bào);2011年

2 王楠;耳蝸神經(jīng)元興奮性損傷與神經(jīng)營養(yǎng)因子抗損傷研究獲成果[N];科技日?qǐng)?bào);2007年

相關(guān)博士學(xué)位論文 前8條

1 姚金晶;Neuritin調(diào)節(jié)神經(jīng)元鉀通道Kv4.2α亞單位表達(dá)及神經(jīng)元興奮性的機(jī)理研究[D];復(fù)旦大學(xué);2014年

2 孫暉;調(diào)節(jié)Kv7通道對(duì)VTA區(qū)DA能神經(jīng)元興奮性及動(dòng)物抑郁樣行為的作用及機(jī)制[D];河北醫(yī)科大學(xué);2016年

3 王玉英;噪聲對(duì)大鼠受損背根節(jié)神經(jīng)元興奮性的作用[D];第四軍醫(yī)大學(xué);2004年

4 郝爽;蟾酥活性成分對(duì)神經(jīng)元興奮性的影響[D];大連理工大學(xué);2012年

5 李澄宇;伴隨活動(dòng)時(shí)序依賴突觸可塑性的突觸前神經(jīng)元興奮性的雙向調(diào)控[D];中國科學(xué)院研究生院（上海生命科學(xué)研究院）;2004年

6 彭小清;膜表面唾液酸化在損傷的初級(jí)感覺神經(jīng)元興奮性異常中的作用[D];中國協(xié)和醫(yī)科大學(xué);2004年

7 李博;HCN通道在蛛網(wǎng)膜下腔出血后神經(jīng)元興奮性紊亂中的作用[D];第三軍醫(yī)大學(xué);2012年

8 賈占峰;神經(jīng)元M通道、Na通道、TRPV1通道功能調(diào)節(jié)及神經(jīng)元興奮性調(diào)節(jié)的研究[D];河北醫(yī)科大學(xué);2009年

相關(guān)碩士學(xué)位論文 前10條

1 秦文娟;Tyramine通過PKC_θ途徑參與疼痛及機(jī)制研究[D];蘇州大學(xué);2016年

2 王希;淀粉樣前體蛋白及其代謝產(chǎn)物Aβ對(duì)神經(jīng)元興奮性的影響[D];大連醫(yī)科大學(xué);2013年

3 喬文惠;孕酮對(duì)迷走神經(jīng)背側(cè)核神經(jīng)元興奮性的影響[D];西北農(nóng)林科技大學(xué);2017年

4 周繼秀;Dynamin 1的磷酸化狀態(tài)與神經(jīng)元興奮性的相關(guān)性研究[D];重慶醫(yī)科大學(xué);2017年

5 貝俊杰;M電流調(diào)節(jié)與大鼠SCG神經(jīng)元興奮性的關(guān)系[D];河北醫(yī)科大學(xué);2007年

6 任盼;單次可卡因注射對(duì)大鼠VTA區(qū)DA神經(jīng)元興奮性突觸傳遞和內(nèi)在興奮性的影響[D];陜西師范大學(xué);2012年

7 秦楊;5-HT在Mes V神經(jīng)元興奮性轉(zhuǎn)型中的作用[D];第四軍醫(yī)大學(xué);2008年

8 李洋;促覺醒肽orexin-A和穩(wěn)態(tài)因子腺苷調(diào)節(jié)大鼠內(nèi)嗅皮層淺層主要神經(jīng)元興奮性及其機(jī)制研究[D];第三軍醫(yī)大學(xué);2010年

9 劉斯佳;BTXA對(duì)脊髓源性痙攣大鼠運(yùn)動(dòng)神經(jīng)元興奮性的影響[D];昆明醫(yī)科大學(xué);2014年

10 賈占峰;神經(jīng)生長因子對(duì)SCG神經(jīng)元興奮性以及M電流和Na電流調(diào)節(jié)的研究[D];河北醫(yī)科大學(xué);2006年

，

本文編號(hào)：2217414